CD19 and acute lymphoblastic leukemia: Sotillo et al. described hemizygous deletions, de novo frameshifts, and missense mutations involving exon 2 in certain B-cell Acute Lymphoblastic Leukemia (B-ALL) relapses and additionally analyzed alternative splicing of CD19 gene [51].